Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD

References

• Adler LA, Spencer TJ, Milton DR, Moore RJ, Michelson D. 2005. Long-term, open-label, study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: An interim analysis. J Clin Psychiatry 66:294–299.
   PubMed Web of Science ®Google Scholar
• Adler LA, Spencer T, Brown TE, Holdnack J, Saylor K, Schuh K, . 2009. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacology 29:44–50.
   PubMed Web of Science ®Google Scholar
• Banaschewski T, Coghill D, Santosh P, Zaddas A, Asherson P, Buitelaar J, . 2006. Long-acting medications for the hyperkinetic disorders. Eur Child Adolesc Psychiatry 15:476–495.
   PubMed Web of Science ®Google Scholar
• Biederman J. 2004. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 65(Suppl 3):3–7.
   PubMedGoogle Scholar
• Biederman J, Mick E, Faraone S. 2000. Age-dependent decline of symptoms of attention-deficit hyperactivity disorder: Impact of remission definition and symptom type. Am J Psychiatry 157:816–818.
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer TJ, Wilens TE, Weisler RH, Read SC, Tulloch SJ. 2005. Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectrum 10:16–25.
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, . 2006. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 59:829–835.
   PubMed Web of Science ®Google Scholar
• Brotman MA, Schmajuk M, Rich BA, Dickstein DJ, Guyer AE, Costello EJ, . 2006. Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children. Biol Psychiatry 60:991–997.
   PubMed Web of Science ®Google Scholar
• Brown TE. 1996. Brown Attention-Deficit Disorder Scales for Adolescents and Adults. London: Psychological Corporation.
   Google Scholar
• Conners CK, Erhardt D, Sparrow E. 1999. CAARS – Adult ADHD Rating Scales – Technical Manual. New York: MHS.
   Google Scholar
• Derogatis LR. 1977. SCL-90-R, administration, scoring & procedures. Manual for the revised version. Baltimore, MD: Johns Hopkins University.
   Google Scholar
• DuPaul G, Power T, Anastopoulos A, Reid R. 1998. ADHD Rating Scale-IV: Checklist, norms, and clinical interpretation. New York: Guilford.
   Google Scholar
• Fayyad J, De Graf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, . 2007. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409.
   PubMed Web of Science ®Google Scholar
• Faraone SV. 2005. The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder. Eur Child Adolesc Psychiatry 14:1–10.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. 2004. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 24:24-29.
   PubMed Web of Science ®Google Scholar
• Gibbins C, Weiss M. 2007. Clinical recommendations in current practice guidelines in diagnosis and treatment of ADHD in adults. Curr Psychiatry Rep 9:420–426.
   PubMedGoogle Scholar
• Jain U, Hechtman L, Weiss M, Ahmed TS, Reiz J, Donnelly GAE, . 2007. Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention deficit hyperactivity disorder: Results of a double-blind placebo-controlled crossover study. J Clin Psychiatry 68:268–277.
   PubMed Web of Science ®Google Scholar
• Koesters M, Becker T, Kilian R, Fegert JM, Weinmann S. 2009. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol 23:733–744.
   PubMed Web of Science ®Google Scholar
• Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. 1993. Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50:565–576.
   PubMed Web of Science ®Google Scholar
• McGough JJ, Barkley RA. 2004. Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry 161:1948–1956.
   PubMed Web of Science ®Google Scholar
• McGough JJ, McCracken JT. 2006. Adult attention deficit hyperactivity disorder: Moving beyond DSM-IV. Am J Psychiatry 163:1673–1675.
   PubMedGoogle Scholar
• Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, . 2003. Atomoxetine in adults with ADHD. Two randomized. placebo-controlled studies. Biol Psychiatry 15:112–120.
   Web of Science ®Google Scholar
• Moll GH, Eysenbach K, Woerner W, Banaschewski T, Schmidt MH, Rothenberger A. 2000. Quantitative and qualitative aspects of obsessive-compulsive behavior in children with attention-deficit hyperactivity disorder compared with tic disorder. Acta Psychiatr Scand 101:389–394.
   PubMedGoogle Scholar
• NICE. 2008. Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. epub 3 November 2008 [www.nice.org.uk].
   Google Scholar
• Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, . 2007. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 21:10–41.
   PubMed Web of Science ®Google Scholar
• Philipsen A, Limberger MF, Lieb K, Feige B, Kleindienst N, Ebner-Priemer U, . 2008. Attention-deficit hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry 192:118–123.
   PubMed Web of Science ®Google Scholar
• Reimherr FW, Marchant BK, Strong RE, Hedges DW, Adler L, Spencer TJ, . 2005. Emotional dysregulation in adult ADHD and response to atomoxetine. Biol Psychiatry 58:125–131.
   PubMed Web of Science ®Google Scholar
• Reimherr FW, Williams ED, Strong RE, Mestas R, Soni P, Merchant BK. 2007. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry 68:93–101.
   PubMed Web of Science ®Google Scholar
• Retz-Junginger P, Retz W, Blocher D, Weijers T, Wender PH, Rösler M. 2002. (Wender Utah Rating Scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults). Nervenarzt 73:830–838.
   PubMed Web of Science ®Google Scholar
• Retz-Junginger P, Retz W, Blocher D, Stieglitz RD, Supprian T, Wender PH, Rösler M. 2003. (Reliability and validity of the German short version of the Wender-Utah Rating Scale for the retrospective assessment of attention deficit/hyperactivity disorder). Nervenarzt 74:987–993.
   PubMed Web of Science ®Google Scholar
• Rösler M, Retz W, Retz-Junginger P, Thome J, Supprian T, Nissen T, . 2004. (Tools for the diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist) Nervenarzt 75:888–895.
   PubMed Web of Science ®Google Scholar
• Rösler M, Retz W, Thome J, Schneider M, Stieglitz R-D, Falkai P. 2006. Psychopathological rating scales for diagnostic use in adults with attention deficit/hyperactivity disorder (ADHD) Eur Arch Psychiatry Clin Neurosci 256(Suppl 1):3–11.
   Google Scholar
• Rösler M, Retz-Junginger P, Retz W, Stieglitz R-D. 2008a. HASE – Homburger ADHS Skalen für Erwachsene. Göttingen: Hogrefe.
   Google Scholar
• Rösler M, Retz W, Retz-Junginger P, Stieglitz R-D, Kessler H, Reimherr F, Wender PH. 2008b. (Attention deficit hyperactivity disorder in adults. Benchmarking diagnosis using the Wender-Reimherr adult ADHD rating scale). Nervenarzt 79:320–327.
   PubMed Web of Science ®Google Scholar
• Rösler M, Fischer R, Ammer R, Ose C, Retz W. 2009. A randomized, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 259:120–129.
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. 1996. Pharmacotherapy of attention deficit hyperactivity disorder across the lifecycle: A literature review. J Am Acad Child Adolesc Psychiatry 35:409–432.
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens TE, Faraone S, Prince J, Gerard K, . 2001. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 58:775–782.
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, . 2005. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 57:456–463.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L. 2007. Efficacy and safety of dexmeythlphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 61:1380–1387.
   PubMed Web of Science ®Google Scholar
• Walcott CM, Landau S. 2004. The relation between disinhibition and emotional regulation in boys with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol 33:772–782.
   PubMed Web of Science ®Google Scholar
• Weiss G, Hechtman LT, Milroy T, Perlman T. 1985. Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry 24:211–220.
   PubMedGoogle Scholar
• Weiss MD, Weiss JR. 2004. A guide to the treatment of adults with ADHD. J Clin Psychiatry 65(Suppl 3):27–37.
   PubMedGoogle Scholar
• Wender PH. 1995. Attention-deficit hyperactivity disorder in adults. Oxford, New York: Oxford University Press.
   Google Scholar
• Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M. 1997. Strukturiertes Klinisches Interview für DSM-IV (SKID). Göttingen: Hogrefe.
   Google Scholar
• Woo BS, Rey JM. 2005. The validity of the DSM-IV subtypes of attention-deficit/hyperactivity disorder. Aust NZ J Psychiatry 39:344–353.
   PubMed Web of Science ®Google Scholar